Automatic Cell Imaging System Market – Regional Insights
North America held the maximum market share in automatic cell imaging system market globally. Rising incidences of cancer cases in the region is expected to bolster the market growth. According to a National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. The number of people with cancer is expected to rise to 19 million by 2024. Moreover, according to a report published in American Cancer Society’s Cancer Journal for Clinicians, around 1,735,350 new cancer cases are estimated to be diagnosed in 2018 in the U.S., including around 87,290 cases of melanoma.
Favorable and constructive policies and regulations, as well as availability of sophisticated healthcare facilities along with rising approvals about the usage of automatic cell imaging system from the governing bodies, are likely to fuel the growth of the automatic cell imaging system market in this region.
The automated microscopy process generates hundreds and thousands of images in a matter of few days; hence, potent image analysis software is required to differentiate between the various appearances of the cell. Manufacturers of automated microscopes generally offer image analysis software for the analyzing of the images that are produced by their hardware. The complexity with this software is to discover the right approach for a definite assay. The analysis desires robustness in order to cope with various situations and they should be fast enough to compute the results for the huge amount of images generated in a short time.
Automatic Cell Imaging System Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients